Spark Investment Management LLC - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 146 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 3.99 and the average weighting 0.4%.

Quarter-by-quarter ownership
Spark Investment Management LLC ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$1,440,000
+22.4%
65,400
-20.1%
0.17%
+12.7%
Q3 2019$1,176,000
-39.7%
81,900
-33.9%
0.15%
+11.1%
Q2 2019$1,950,000
+58.9%
123,872
+23.6%
0.14%
+87.5%
Q2 2018$1,227,000
-11.5%
100,200
-30.9%
0.07%
-19.1%
Q1 2018$1,386,000
+842.9%
145,000
+1267.9%
0.09%
+323.8%
Q2 2015$147,00010,6000.02%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,705,392$43,607,0007.88%
Bain Capital Life Sciences Investors, LLC 3,080,237$78,762,0004.46%
DAFNA Capital Management LLC 587,756$15,029,0003.57%
RTW INVESTMENTS, LP 7,463,291$190,836,0002.98%
SILVERARC CAPITAL MANAGEMENT, LLC 200,000$5,114,0002.79%
Evolutionary Tree Capital Management, LLC 122,473$3,132,0001.85%
Parkman Healthcare Partners LLC 303,268$7,755,0001.80%
Eagle Health Investments LP 161,125$4,120,0001.62%
BRIDGER MANAGEMENT, LLC 588,910$15,058,0001.41%
Woodline Partners LP 1,777,000$45,438,0001.01%
View complete list of DICERNA PHARMACEUTICALS INC shareholders